Colm joined the Eye Research Group Oxford team in July 2013, as an Ophthalmic Technician. With a background in Forensic Psychology and Astrophysics he has transferred his analytical skills to gain insight into the development of all stages of clinical trials, from conception to completion. This was recognised in 2015 when he was promoted to the role of Clinical Research Analyst: A varied role that combines research coordination with methodological set up and analysis. Colm successfully completed an MSc in Evidence Based Healthcare at the University of Oxford in 2017. His dissertation focused on the impact of ocular disease on circadian rhythm. Colm is currently working on the SANDMAN trial: A randomised placebo-controlled trial to assess the effect of melatonin on circadian sleep-wake disturbances in ocular disease. Fuelled by a belief that it is vital that the NHS has access to the most cost-effective treatment for a variety of conditions Colm is proud to contribute to high quality research within the NHS.